EPIX - ESSA Pharma GAAP EPS of -$0.20 August, 04 2022 08:47 AM ESSA Pharma Inc. ESSA Pharma press release ( NASDAQ: EPIX ): FQ3 GAAP EPS of -$0.20 (vs. -$0.21 Y/Y). At June 30, 2022, the Company had available cash reserves and short-term investments of $174.6 million. For further details see: ESSA Pharma GAAP EPS of -$0.20